Eef Schimmelpennink Email and Phone Number
Eef Schimmelpennink work email
- Valid
- Valid
- Valid
- Valid
- Valid
Eef Schimmelpennink personal email
Eef Schimmelpennink phone numbers
Biopharmaceutical public company CEO with over 20 years of experience spanning R&D, Commercial, Public and Private Finance, Business Development and Manufacturing. Consistent track-record in driving growth by defining a clear vision and strategy, aligning the organization and external stakeholders around it, and focusing on disciplined execution to deliver results. Effective cross-functional leader respected for engaging and collaborative leadership style, ability to build teams and create a culture that attracts talent and gets the best out of people. Inspiring communicator and seasoned negotiator who bridges breakthrough ideas, exceptional people and the financing community.
-
President And CeoLenz Therapeutics Mar 2021 - PresentSan Diego, California, UsLENZ Therapeutics [NASDAQ : LENZ] is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors. For more information please visit: LENZ-Tx.com
-
Member Board Of DirectorsIbio, Inc. Jun 2021 - PresentSan Diego, Ca, Us -
Chair Of The Board Of DirectorsPipeline Therapeutics Feb 2022 - PresentSan Diego, Ca, Us -
Ceo And PresidentPfenex Inc. (Pfnx : Nyse) Aug 2017 - Oct 2020Successfully completed ambitious 3-year turnaround from near bankruptcy to attractive $516m/83% premium acquisition, by providing vision and leadership, aligning team and culture, and creating external stakeholder confidence through relentless focus on execution. Pfenex Inc. (PFNX : NYSE) is a US listed biopharmaceutical company using proprietary Pfenex Expression Technology™ to develop next generation and novel protein therapeutics with the aim to meaningfully improve existing treatment paradigms and create novel therapies for critical diseases. Acquired by Ligand Pharmaceuticals (NASDAQ: LGND) in Q3 2020.
-
CeoAlvotech Oct 2015 - Aug 2017Reykjavik, -, IsLed Alvotech through a critical growth phase, aligned R&D, manufacturing and commercial capabilities across a portfolio of 7 monoclonal antibodies and set long term strategy.Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high-quality biosimilar medicines. -
Vice President - Global Sterile InjectablesPfizer Sep 2015 - Nov 2015New York, New York, UsLed the integration of the Hospira Injectable business into Pfizer and subsequently led Global Marketing of newly formed $6Bn Sterile Injectable business. -
Vice President - Global GenericsHospira Dec 2012 - Aug 2015Lake Forest, Il, UsAccountable for the Global Generics business unit with 2014 revenue of $2.6B, and a four-year 11% revenue and 19% margin CAGR. -
Director Of Specialty Injectable Pharma Marketing Emea & Director Of Distributor Operations EmeaHospira Mar 2011 - Dec 2012Lake Forest, Il, UsDelivered a turnaround on the EMEA Generics P&L with revenues of $275M in 2012 representing 9% YOY growth.
-
Vice President Marketing And SalesSynthon Bv Jan 2008 - Apr 2011Nijmegen, Nl -
Director Business DevelopmentSynthon Bv Jan 2007 - Dec 2007Nijmegen, Nl
-
Business Development ManagerSynthon Bv Apr 2006 - Dec 2006Nijmegen, Nl
-
Senior International Product ManagerSynthon Bv Jan 2005 - Mar 2006Nijmegen, Nl
-
International Product ManagerSynthon Bv Oct 2002 - Dec 2004Nijmegen, Nl
-
International Product ManagerNumico Dec 2000 - Sep 2002Paris, Fr -
Researcher Product DevelopmentNumico Sep 1997 - Nov 2000Paris, Fr
Eef Schimmelpennink Skills
Eef Schimmelpennink Education Details
-
Wageningen University & ResearchBioprocess Engineering -
Qut (Queensland University Of Technology)Bioprocess Engineering
-
Business School ArnhemBusiness
Frequently Asked Questions about Eef Schimmelpennink
What company does Eef Schimmelpennink work for?
Eef Schimmelpennink works for Lenz Therapeutics
What is Eef Schimmelpennink's role at the current company?
Eef Schimmelpennink's current role is President and CEO at LENZ Therapeutics[NASDAQ : LENZ].
What is Eef Schimmelpennink's email address?
Eef Schimmelpennink's email address is ee****@****ech.com
What is Eef Schimmelpennink's direct phone number?
Eef Schimmelpennink's direct phone number is +35452*****
What schools did Eef Schimmelpennink attend?
Eef Schimmelpennink attended Wageningen University & Research, Qut (Queensland University Of Technology), Business School Arnhem.
What skills is Eef Schimmelpennink known for?
Eef Schimmelpennink has skills like Pharmaceutical Industry, Business Development, Pharmaceutical Sales, Product Development, Strategy, Regulatory Affairs, Biotechnology, Hospital Sales, Cross Functional Team Leadership, Product Launch, Pharmaceutics, Generic Programming.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial